The SACC Project (Shared Addiction Care Copenhagen) will develop and implement a decentralised hepatitis C shared care model in Copenhagen with the aim of decreasing hepatitis C (HCV) related transmission, morbidity and mortality among injection drug users (IDUs). The study terminated 31st May 2017. Please see the final report here.
After the study finished the city of Copenhagen decided to continue the SACC idea and it is a part of the care in all the 11 counselling centres offering drug treatment in Copenhagen.
The 3 year project is funded by the Capital Region of Denmark and the City of Copenhagen. The project involves an expanded collaboration between 12 counselling centres offering drug treatment in Copenhagen, City of Copenhagen and the Department of Infectious Diseases and Rheumatology, Rigshospitalet.
Most IDUs in Denmark have never been tested for HCV infection. Among those with chronic HCV infection, only a third is being followed at a hospital clinic and few of these have received HCV treatment. The physical and organisational divide between counselling centres and the hospital have instigated low retention rates in HCV treatment and care of IDUs. Often, clients referred to treatment at the hospital never turn up or have a sporadic contact with the hospital clinic.
In recent years, substantial innovation has taken place within HCV diagnosis, evaluation of the severity of liver disease, and treatment of HCV. This strengthens the opportunity to break down barriers and facilitate integration of diagnosis and treatment of HCV locally at counselling centres.
The SACC project will entail:
· Development of a shared database (Hospital and counselling centres offering drug treatment). A "real time" database will be developed where data from relevant existing databases are gathered in a common patient chart. The health professionals at counselling centres and the Department of Infectious Diseases and Rheumatology will have access to the data. This development will bank on CHIPs experience with database-development and implementation from previous research projects.
· HCV screening and clinical evaluation: HCV testing, non-invasive evaluation of liver fibrosis (fibroscanning) and further clinical evaluation of clients in order to identify persons eligible for HCV treatment, will take place locally at the counselling centres. Prior to this phase, a strengthening of teaching and information about hepatitis C, aimed at both clients and staff, will take place.
· Implementation of a shared care treatment model. The shared care model will first be implemented in three pilot counselling centres. Prescription of medicine and monitoring of treatment outcome is the responsibility of the Department of Infectious Diseases, while it is responsibility of the counselling centres to ensure compliance and that different tests are carried out as prescribed. The database will be programmed to generate alarms if tests are not performed, or if the results require an intervention. The shared care model will thereafter be validated in the nine remaining counselling centres.
· Research. Collection of data on HCV infection, treatment and outcome from a large population of IDUs will enable the production of scientific publications and presentations on the health status of IDUs in general and HCV-related disease and integrated hepatitis C treatment and care in particular. This is done as means to strengthen research in health interventions aiming to secure inclusion of vulnerable and marginalized groups - and reduce inequality in access to health.
The project will run from June 2014 to May 2017. A Project Advisory Board is established with representatives from: Social Services Administration, City of Copenhagen; counselling centres; CHIP and; Department of Infectious Diseases and Rheumatology, Rigshospitalet.
For further information please contact study coordinator Tina Bruun email@example.com